Editas Medicine, Inc. (EDIT) Ownership

$1.43

north_east
$0.09 (6.72%)
Day's range
$1.34
Day's range
$1.52

Editas Medicine, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK FUNDING, INC. /DE 02/07/2025 7.31 M $9.28 M   -8.93% 8.86%
VANGUARD GROUP INC 02/11/2025 6.82 M $8.67 M   2.15% 8.27%
MILLENNIUM MANAGEMENT LLC 02/14/2025 2.75 M $3.49 M   -18.02% 3.33%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 2.16 M $2.74 M   -4.75% 2.62%
STATE STREET CORP 02/14/2025 1.87 M $2.38 M   -23.96% 2.27%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.81 M $2.30 M   -4.19% 2.19%
GOLDMAN SACHS GROUP INC 02/11/2025 1.79 M $2.27 M   53.03% 2.17%
TWO SIGMA ADVISERS, LP 02/14/2025 1.66 M $2.10 M   46.77% 2.01%
TWO SIGMA INVESTMENTS, LP 02/14/2025 1.65 M $2.09 M   21.38% 2.00%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 1.45 M $1.84 M   100.00% 1.76%
BALYASNY ASSET MANAGEMENT L.P. 02/14/2025 1.30 M $1.65 M   647.32% 1.58%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 1.17 M $1.49 M   30.36% 1.42%
UBS GROUP AG 02/14/2025 1.12 M $1.42 M   171.57% 1.35%
JANE STREET GROUP, LLC 02/14/2025 1.07 M $1.36 M   24.27% 1.30%
AQR CAPITAL MANAGEMENT LLC 02/14/2025 1.07 M $1.36 M   184.47% 1.30%
MONACO ASSET MANAGEMENT SAM 02/10/2025 1.07 M $1.36 M   100.00% 1.30%
WOODLINE PARTNERS LP 02/14/2025 838,419 $1.06 M   -6.89% 1.02%
JPMORGAN CHASE & CO 02/12/2025 787,599 $1.00 M   2.13% 0.95%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 608,249 $772,476   -1.46% 0.74%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2025 528,836 $671,622   -2.09% 0.64%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 440,622 $559,590   31.83% 0.53%
TANG CAPITAL MANAGEMENT LLC 02/14/2025 400,000 $508,000   100.00% 0.48%
STIFEL FINANCIAL CORP 02/13/2025 337,158 $428,198   -46.04% 0.41%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 316,614 $402,100   23.66% 0.38%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 02/14/2025 272,430 $345,986   100.00% 0.33%
HENNION & WALSH ASSET MANAGEMENT, INC. 01/15/2025 267,758 $340,053   18.08% 0.32%
BANK OF NEW YORK MELLON CORP 02/04/2025 243,376 $309,088   0.19% 0.30%
RAYMOND JAMES FINANCIAL INC 02/13/2025 238,967 $303,488   100.00% 0.29%
AMERIPRISE FINANCIAL INC 02/14/2025 227,609 $289,064   282.70% 0.28%
FMR LLC 02/13/2025 225,657 $286,585   11.11% 0.27%
PRUDENTIAL FINANCIAL INC 02/11/2025 196,977 $250,161   35.49% 0.24%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 193,595 $244,000   100.00% 0.23%
SQUAREPOINT OPS LLC 02/14/2025 189,462 $240,617   104.35% 0.23%
WELLS FARGO & COMPANY/MN 02/13/2025 186,329 $236,638   -63.09% 0.23%
BARCLAYS PLC 02/13/2025 181,238 $229,000   1.53% 0.22%
D. E. SHAW & CO., INC. 02/14/2025 179,515 $227,984   -2.82% 0.22%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 176,703 $224,413   2.75% 0.21%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 02/14/2025 150,000 $190,500   100.00% 0.18%
BNP PARIBAS ARBITRAGE, SNC 02/14/2025 144,060 $182,956   162.95% 0.17%
RHUMBLINE ADVISERS 01/30/2025 140,717 $178,697   -0.82% 0.17%
ALLIANCEBERNSTEIN L.P. 02/12/2025 133,630 $169,710   -0.89% 0.16%
ARISTIDES CAPITAL LLC 02/13/2025 131,900 $167,513   100.00% 0.16%
GREEN ALPHA ADVISORS, LLC 01/13/2025 111,628 $141,768   157.61% 0.14%
XTX TOPCO LTD 02/13/2025 105,056 $133,421   99.89% 0.13%
02/14/2025 104,816 $133,116   100.00% 0.13%
INVESCO LTD. 02/13/2025 100,164 $127,209   9.21% 0.12%
CITIGROUP INC 02/12/2025 99,103 $125,861   50.76% 0.12%
LOS ANGELES CAPITAL MANAGEMENT LLC 02/04/2025 98,839 $125,526   -15.98% 0.12%
GROUP ONE TRADING, L.P. 02/14/2025 93,715 $119,018   2,638.60% 0.11%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 02/14/2025 86,347 $110,000   16.03% 0.10%

Editas Medicine, Inc. institutional Ownership - FAQ's

During the previous two years, 308 institutional investors and hedge funds held shares of Editas Medicine, Inc.. The most heavily invested institutionals were:

BlackRock Funding, Inc. /DE: 7.31 M

VANGUARD GROUP INC: 6.82 M

MILLENNIUM MANAGEMENT LLC: 2.75 M

DIMENSIONAL FUND ADVISORS LP: 2.16 M

STATE STREET CORP: 1.87 M

GEODE CAPITAL MANAGEMENT, LLC: 1.81 M

61.85% of Editas Medicine, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 70.04 M shares in the last 24 months. This purchase volume represents approximately $100.15 M in transactions.